Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$546M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$362M |
| 4 |
Meta Platforms (Facebook)
META
|
+$350M |
| 5 |
Coca-Cola
KO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$1.04B |
| 2 |
Palantir
PLTR
|
+$800M |
| 3 |
Apple
AAPL
|
+$516M |
| 4 |
Netflix
NFLX
|
+$326M |
| 5 |
NVIDIA
NVDA
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 15.15% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Communication Services | 10.55% |
| 5 | Financials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ZENV
3201
DELISTED
Zenvia
ZENV
| $144K | ﹤0.01% |
107,401
-10,800
| -9% | -$16K |
2022 Q1
14 quarters
|
|
|
PAL
3202
Proficient Auto Logistics
PAL
$100M
| $143K | ﹤0.01% |
+20,796
| New | +$153K |
2025 Q3
0 quarters
|
|
3203
First Guaranty Bancshares
FGBI
$138M
| $142K | ﹤0.01% |
17,706
-500
| -3% | -$4.18K |
2024 Q2
5 quarters
|
|
|
ARDT
3204
Ardent Health
ARDT
$1.59B
| $142K | ﹤0.01% |
10,700
-59,800
| -85% | -$748K |
2025 Q1
2 quarters
|
|
3205
Anixa Biosciences
ANIX
$101M
| $141K | ﹤0.01% |
42,764
+15,091
| +55% | +$47.7K |
2024 Q3
4 quarters
|
|
|
OMSE
3206
OMS Energy Technologies
OMSE
$188M
| $141K | ﹤0.01% |
+33,135
| New | +$209K |
2025 Q3
0 quarters
|
|
3207
Research Frontiers
REFR
$20.7M
| $140K | ﹤0.01% |
88,100
+1,400
| +2% | +$2.12K |
2023 Q2
9 quarters
|
|
3208
American Shared Hospital Services
AMS
$8.78M
| $139K | ﹤0.01% |
49,800
-16,900
| -25% | -$42.7K |
2021 Q3
16 quarters
|
|
3209
Cellectar Biosciences
CLRB
$13.7M
| $139K | ﹤0.01% |
+24,900
| New | +$123K |
2025 Q3
0 quarters
|
|
3210
BioVie
BIVI
$12.1M
| $139K | ﹤0.01% |
+72,918
| New | +$295K |
2025 Q3
0 quarters
|
|
3211
SurgePays
SURG
$7.5M
| $139K | ﹤0.01% |
49,300
+4,100
| +9% | +$11.6K |
2024 Q2
5 quarters
|
|
|
TOYO
3212
TOYO Co
TOYO
$187M
| $138K | ﹤0.01% |
+24,000
| New | +$117K |
2025 Q3
0 quarters
|
|
|
FPAY
3213
DELISTED
FlexShopper
FPAY
| $137K | ﹤0.01% |
213,980
-9,800
| -4% | -$8.48K |
2019 Q1
26 quarters
|
|
|
BRAG
3214
Bragg Gaming Group
BRAG
$36M
| $137K | ﹤0.01% |
45,100
-72,000
| -61% | -$254K |
2023 Q2
9 quarters
|
|
3215
SCYNEXIS
SCYX
$40.6M
| $134K | ﹤0.01% |
21,825
+1,850
| +9% | +$12.5K |
2022 Q4
11 quarters
|
|
3216
Marti Technologies
MRT
$161M
| $134K | ﹤0.01% |
65,656
+1,156
| +2% | +$2.94K |
2024 Q4
3 quarters
|
|
3217
ICZOOM Group
IZM
$2.14M
| $133K | ﹤0.01% |
11,140
+7,373
| +196% | +$92.2K |
2025 Q2
1 quarter
|
|
|
FORA
3218
DELISTED
Forian
FORA
| $132K | ﹤0.01% |
58,797
+24,597
| +72% | +$50.2K |
2022 Q2
13 quarters
|
|
|
SCPH
3219
DELISTED
scPharmaceuticals
SCPH
| $132K | ﹤0.01% |
+23,216
| New | +$119K |
2025 Q3
0 quarters
|
|
3220
Health Catalyst
HCAT
$133M
| $131K | ﹤0.01% |
+45,869
| New | +$157K |
2025 Q3
0 quarters
|
|
|
VNTG
3221
Vantage Corp
VNTG
$19.6M
| $131K | ﹤0.01% |
+17,900
| New | +$95K |
2025 Q3
0 quarters
|
|
3222
Amprius Technologies
AMPX
$1.38B
| $130K | ﹤0.01% |
12,400
-1,334,200
| -99% | -$10.5M |
2024 Q3
4 quarters
|
|
3223
SES AI
SES
$290M
| $130K | ﹤0.01% |
+78,000
| New | +$93.3K |
2025 Q3
0 quarters
|
|
3224
UNIFI
UFI
$113M
| $130K | ﹤0.01% |
27,300
+300
| +1% | +$1.38K |
2021 Q3
16 quarters
|
|
3225
Cytosorbents Corp
CTSO
$11.9M
| $126K | ﹤0.01% |
6,740
+908
| +16% | +$17.9K |
2022 Q1
14 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2025 Portfolio in Review
As of Q3 2025, Renaissance Technologies held 4,038 positions worth $75.8B, up 0.77% from $75.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $5.41B in Q3 2025, closing 581 positions and reducing 1,457 holdings. Its most notable exit was GE Aerospace, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class C worth $419M.
- Renaissance Technologies's largest Q3 2025 buy was Alphabet (Google) Class C: 1,720,002 shares worth $419M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2025, an estimated $546M increase.
- Renaissance Technologies's biggest Q3 2025 reduction was Robinhood, cutting an estimated $1.04B.
- Renaissance Technologies fully exited GE Aerospace in Q3 2025, selling an estimated $235M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.8B portfolio in Q3 2025.
- Renaissance Technologies opened 515 new positions and closed 581 in Q3 2025.
- Renaissance Technologies's portfolio value rose 0.77% quarter-over-quarter to $75.8B.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.